PRG.L Regulatory News (PRG)

10 Aug 2007 08:30

Premier Research Group10 August 2007 For immediate release 10 August 2007 Premier Research Group plc Trading update The Board of Premier Research Group plc (AIM: PRG) ('Premier Research','Company' or 'Group'), the international pharmaceutical services group, hasnoted the recent fall in its share price and whilst recognising the volatilityin the UK stock market generally, provides the following update. Following the announcement on 13 July 2007 of the acquisitions of ARS andD-Target and the pre-close update, Premier Research is pleased to announce thatthe integration of the new businesses is progressing well. The data managementgroups in the US are working well together and the integration of the medicaldevices capability within the International division is progressing to plan.Several cross-selling opportunities have already begun to develop across theGroup. New order intake across the Group remains strong and the backlog of orderscontinues to grow with over £8 million of new orders having been won since 1July, improving still further the longer term visibility. As the Company movesinto its traditionally busiest season, with over 80% of full year expectationsalready booked or scheduled for delivery, the Board maintains confidence ofachieving its consensus forecasts for the full year. Enquiries: Premier Research Group plc Tel: 01344 752375Dr Simon Yaxley, Chief Executive Officerwww.premier-research.com Buchanan Communications Tel: 020 7466 5000Lisa Baderoon, Rebecca Skye Dietrich Evolution Securities Tel: 020 7071 4300Simon Leathers This information is provided by RNS The company news service from the London Stock Exchange